期刊
JOURNAL OF PAIN
卷 6, 期 6, 页码 356-363出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.jpain.2005.01.359
关键词
postherpetic neuralgia; pain; medications; health-related quality of life
Persons aged > 65 years with pain caused by postherpetic neuralgia (PHN) were recruited via advertisements in 24 US newspapers and were mailed a questionnaire that addressed pain intensity (average, worst, least, current), pain interference (with general activity, mood, relations with other people, sleep, enjoyment of life), and health-related quality of life (using the EuroQoL health measure [EQ-5D] and a global rating scale). Respondents also were asked about their use of medication for shingles pain. A total of 385 persons completed the survey; 61% were > 75 years of age. Mean (+/- standard deviation) duration of PHN was 3.3 (+/- 4.0) years. Only about one half had taken prescription medication for shingles pain during the prior week; dosages were typically low. Mean average, worst, least, and current pain caused by shingles (0- to 10-point scale) was 4.6 ( +/- 2.1), 6.0 ( +/- 2.4), 2.9 (+/- 2.3), and 4.0 ( +/- 2.7), respectively. Mean pain interference with general activity, mood, relations with other people, sleep, and enjoyment of life (0- to 10-point scale) was 3.7 ( +/- 3.1), 4.3 ( +/- 2.9), 3.0 ( +/- 2.8), 3.8 ( +/- 2.9), and 4.5 ( +/- 3.1), respectively. The mean EQ-5D health index score was 0.61; respondents rated their overall health as 65.7 ( +/- 21.1) on a 100-point scale. PHN causes substantial pain, dysfunction, and poor health-related quality of life in older persons, many of whom might be suboptimally treated. Perspective: many older persons (age > 65 years) with PHN experience longstanding, severe, and debilitating pain and poor health-related quality of life, levels of dissatisfaction with treatment are high. Our study highlights the need for improved management of this disease. (c) 2005 by the American Pain Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据